DVYSR — Devyser Diagnostics AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK1.89bn
- SEK1.86bn
- SEK216.90m
Annual cashflow statement for Devyser Diagnostics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.9 | -21.2 | -52 | -58.9 | -58.3 |
| Depreciation | |||||
| Non-Cash Items | 0.002 | 0.981 | 0.593 | 7 | 13.5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.06 | -2.27 | 2.32 | -30.9 | -29.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.627 | -16.5 | -40.5 | -69.7 | -46.8 |
| Capital Expenditures | -3.42 | -8.8 | -25.8 | -32 | -76.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.3 | -1.52 | 1.94 | 0 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.71 | -10.3 | -23.9 | -32 | -76.9 |
| Financing Cash Flow Items | 0.001 | -28.2 | -3 | 0 | -0.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.27 | 396 | 48.9 | -0.2 | 7.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.04 | 369 | -14 | -101 | -118 |